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Background: High concentrations of plasma leptin and the release of pro-inflammatory cytokines in leptin-resistance
in obesity have been reported to trigger endothelial dysfunction. The objective of this study was to elucidate the role
of quercetin in modulating leptin-induced inflammation as assessed by the levels of Ob-Ra expression, ERK1/2
phosphorylation, NF-kappa B activation and TNF-alpha secretion in umbilical vein endothelial cells (HUVECs) in vitro.
Findings: HUVECs were exposed to either control levels (0 ng/ml) or 500 ng/mL leptin (L) for 48 hours, followed by
control or 125 uM quercetin (Q) for another 6 h. The experimental groups were as follows: L0Q0, L0Q125, L500Q0,
L500Q125. The presence of the short chain leptin receptor isoform Ob-Ra in HUVECs was determined by Western blot
and immunocytochemistry analyses. Ob-Ra expression, ERK1/2 phosphorylation, NF-kappa B activation and TNF-alpha
secretion were quantified by ELISA, and NF-kappa B activationby immunofluorescence staining. Our results showed
that Ob-Ra expression, ERK1/2 phosphorylation and NF-kappa B activation increased significantly after 500 ng/mL leptin
exposure (1.8x, 1.5x, 6.2x for Ob-Ra, ERK1/2 and NF-kappa B, respectively), but were reduced by addition of 125 uM
quercetin (0.7x, 0.3x and 0.4x for Ob-Ra, ERK1/2 and NF-kappa B, respectively), and that quercetin could also partially
suppress leptin-induced TNF-alpha secretion (3.8x) by 0.8x.
Conclusion: Exposure of HUVECs to leptin up-regulated Ob-Ra expression and elevated ERK1/2 phosphorylation and
NFkB activation, and increased TNF-alpha secretion. These effects strongly suppressed by quercetin, with the exception
of TNF-alpha which was partially suppressed. The findings might be of clinical significance, as endothelial dysfunction
that could lead to cardiovascular disease is preventable, and quercetin is a natural compound found in various plants
and fruits.
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Obesity has become a global health problem, with the
prevalence of overweight and obesity reaching critical
levels throughout the world, including Indonesia. A na-
tional survey in 2007 in 12 Indonesian provinces showed
that 18.8% of the population older than 15 years old are
obese [1]. Obesity is a major risk factor for cardiovascular* Correspondence: rasjadindra@yahoo.com
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reproduction in any medium, provided the ordisease, hypertension, dyslipidemia and diabetes mellitus,
all of which reduce both the quality of life and life expect-
ancy. Obesity is associated with excessive adipose tissue
accumulation due to excessive energy intake and insuffi-
cient energy expenditure [2], and is characterized by the
alteration of leptin levels, a cytokine produced by adipo-
cytes and one of the regulators of energy metabolism.
Studies have shown that most obese patients are leptin re-
sistant, and high leptin levels were observed in these indi-
viduals [3]. An association between leptin and increased
cardiovascular risk has been reported [4], and is associated
with increased levels of inflammatory factors exhibitingd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sidered as a state of low-grade inflammation [8]; previous
research has shown that atherosclerosis is the result of
chronic inflammation, and early atherosclerosis formation
is induced by pro-inflammatory cytokines and other pro-
teins produced by inflammatory cells [9,10].
In obesity-related high plasma leptin conditions, in-
flammation occurs when signal transduction pathways
are activated, such as activation of NFκΒ, by the binding
of leptin to its receptor (Ob-R), and subsequent release
of the inflammation factors, for instance tumour necro-
sis factor alpha (TNFα) [11]. Our preliminary results re-
vealed that 500 ng/ml leptin decreases cell proliferation
and increases TNFα, monocyte chemoattractant protein-
1 (MCP-1), and intracellular Ca2+ levels in human um-
bilical vein endothelial cells (HUVECs) [12].
Quercetin, a flavonoid compound found in plants
and fruits, has been reported to have anti-inflamma-
tory effects [13], which are mediated through the in-
hibition of pro-inflammatory cytokines [14]. The aim
of this study was to investigate the effect of quercetin
in modulating the expression of Ob-Ra, phosphoryl-
ation of ERK1/2, activation of NFκB and secretion of
TNFα in leptin-induced human umbilical vein endo-
thelial cells (HUVECs) in vitro.Methods
Samples
Human umbilical vein endothelial cells (HUVECs)
were obtained from umbilical cords of patients that
have undergone cesarean section in Dr. Syaiful Anwar
Hospital, Malang, after obtaining informed consent.
This research was approved by the institutional re-
search ethical committee from the Faculty of Medi-
cine, Brawijaya University, Malang.Cell culture and treatment
HUVECs were isolated and cultured as described pre-
viously [15,16]. Briefly, HUVECs were cultured in M-
199 medium (Sigma-Aldrich, USA) supplemented with
10% fetal calf serum (Biochrom, Germany), 0.0292 g/
mL L-glutamine (Gibco, USA), 50 U/mL penicillin
(Gibco, USA), and 50 mg/mL streptomycin (Gibco,
USA), at 37°C in a 5% CO2 incubator. Human re-
combinant leptin (500 ng/mL; Sigma-Aldrich, USA)
dissolved in dimethyl sulfoxide/DMSO (MPBio, USA)
was added to HUVECs and incubated for 48 hours.
Quercetin (125 μM; Sigma-Aldrich, USA) dissolved in
methylcellulose (MPBio, USA), was added to leptin-
exposed HUVECS for 6 hours. HUVECs that were not
exposed to leptin were treated with 0 μM and 125 μM
quercetin for 6 hours. Quercetin concentration of 125
μM was reported to have marginal cell toxicity [17].The experimental groups were: L0Q0 without leptin
and quercetin (control, with DMSO and methylcellu-
lose only); L0Q125 without leptin but with 125 μM
quercetin; L500Q0 with 500 ng/mL leptin but without
quercetin; L500Q125 with 500 ng/mL leptin and
125 μM quercetin. The experiments were repeated 5
times for each group.
Western blot analysis
Proteins were extracted from HUVECs by using ma-
mmalian protein extraction reagent (Pierce, IL). Pro-
tein concentrations were determined using Coomassie
protein reagent (Bio-Rad, CA). Thirty micrograms of
total protein was loaded per lane and separated by
7.5% sodium dodecyl sulfate-Tris-glycine polyacryl-
amide gel electrophoresis. Proteins were transferred
to nitrocellulose membranes and blocked overnight in
Tris-buffered saline (TBS) containing 0.1% Tween and
5% nonfat dry milk. Membranes were probed with
rabbit polyclonal antibody directed against either hu-
man short leptin receptor (ObRa) or human phos-
phorylated ERK1/2 or human p65 NFκB antibodies
(1:1000; Cell Signaling, MA), or mouse antihuman
β-actin monoclonal antibody (1:1.000; Santa Cruz
Biotech, USA), then were detected using Biotin-
conjugated goat anti-rabbit IgG (Santa Cruz Biotech,
USA). Visualization was done after incubation with
streptavidin-alkaline phosphatase conjugate (Invitrogen,




HUVECs were fixed with methanol in glass slides, then
gently rinsed with phosphate buffer solution (PBS).
Normal human serum (1:10 dilution) (MPBio, USA)
was applied and incubated for 20–30 minutes at 37°C.
Rabbit anti-human Ob-Ra antibody (1:100) (Santa Cruz
Biotech, USA) was applied and the specimens were
incubated overnight at 4°C. Labelled anti rabbit IgG-SA-HRP
(KPL, USA) was applied for 60 minutes, then substrate-
chromogen solution 3,3′-diaminobenzidine was added,
and the specimens were incubated for 10 minutes.
Hematoxylin counterstaining was performed to stain
the nucleus. The slides were then covered with cover slips.
Ezyme linked immunosorbent assay
Cell lysate were obtained from harvested HUVECs,
then ELISA was performed to quantify the level of
Ob-Ra (BioSource International, USA), total phos-
phorylated ERK1/2 (Assay Designs, USA), and p50/
p65 NFκB (Imgenex, USA).
ELISA for secreted TNFα (Bender MedSystem, Austria)
was conducted using the supernatant of HUVECs culture.
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Sub-confluent HUVECs grown on cover slips were fixed
with methanol at room temperature for 10 minutes, la-
beled with 10 μg/mL antihuman p50/p65 NFκB antibody
(Thermo Scientific, USA) for 1 hour, washed 3 times
with PBS, then incubated with 8 μg/mL FITC-labeled
goat anti-rabbit IgG (Santa Cruz Biotechnology Inc,
USA) for 1 hour. Bound antibody was detected using
Fluo view 1000 confocal microscope (Olympus, Japan)
equipped for epiluminescence.Statistical analyses
Results were the average of at least five repeats. Differ-
ences between groups were determined by ANOVA,
followed by Tukey’s test (SPSS vs. 17). All data were
shown as means ± SD, and p < 0.05 was considered sta-
tistically significant.
Results
Ob-Ra was expressed in HUVECs
The short isoform of leptin receptor (Ob-Ra) was
expressed in HUVECs, as demonstrated by Western
blot analysis shown in Figure 1A. After leptin induc-
tion the expression of Ob-Ra was increased almost
two folds as compared to control (band intensities are
1488 ± 355.4 vs. 2586 ± 380.8, without and with leptin
exposure, p = 0.001). Immunocytochemistry staining
confirmed the increased expression of Ob-Ra in
leptin-induced HUVECs (Figure 1B).A
B
1
Figure 1 Ob-Ra was expressed in HUVECs. (A) Western blot analysis of
increased Ob-Ra expression (without (lane 1) and with (lane 2) leptin expos
control (without leptin induction). (B) Confirmation of increased Ob-Ra exp
antibody against Ob-Ra (without (panel 1) and with (panel 2) leptin exposuQuercetin down-regulated leptin receptor expression
The short isoform of leptin receptor (Ob-Ra) expres-
sion was significantly increased 1.8x after 48 hours
leptin exposure (500 ng/ml) (9966 ± 194.0 vs. 18116 ±
1823 ng/mL, L0Q0 vs. L500Q0, p = 10-4). Quercetin
(125 μM) down-regulated the leptin-induced Ob-Ra
expression by 0.7x(13449 ± 235.3 vs. 18116 ± 1823 ng/
mL, L500Q125 vs. L500Q0, p = 0.028). Quercetin
alone (L0Q125) increased leptin receptor expression
(13660 ± 1452 vs. 9966 ± 194.0 ng/mL, L0Q125 vs.
L0Q0, p = 0.020) (Figure 2).
Quercetin reduced leptin-induced ERK1/2
phosphorylation
Quantitative measurement by ELISA revealed a 1.5x
higher total phosphorylated ERK1/2 level in leptin-
induced HUVECs (85.00 ± 10.44 vs. 129.3 ±22.55 ng/
mL, L0Q0 vs. L500Q0, p = 0.012). Addition of 125 μM
quercetin (L500Q125) reduced ERK1/2 phosphorylation
in leptin-induced HUVECs by 0.3x (40.00 ± 1.73 vs.
129.3 ±22.55 ng/mL, L500Q125 vs. L500Q0, p = 10-4).
We observed that quercetin alone also reduced ERK1/2
total phosphorylation (43.33 ± 4.93 vs. 85.00 ± 10.44 ng/
mL, L0Q125 vs. L0Q0, p = 0.016) (Figure 3).
Quercetin inhibited leptin-induced NFκB activation
FITC immunolabeling was used to determine the NFκB
activation. As shown in Figure 4A signal density was
increased after HUVECs was exposed to 500 ng/mL
leptin as compared to control. Quercetin alone did not2
Ob-Ra in HUVECs showed that exposure of 500 ng/mL leptin for 48 h
ure). β-actin expression in leptin-induced HUVECs was similar with





Figure 2 Quercetin down-regulates leptin receptor expression. Ob-Ra expression measured by ELISA was increased after 500 ng/mL leptin
exposure, and 125 μM quercetin addition was able to decrease the expression of Ob-Ra in leptin-induced HUVECs. L0Q0 control HUVECs without
leptin and quercetin; L0Q125 without leptin, but with 125 μM quercetin; L500Q0 with 500 ng/mL leptin, but without quercetin; L500Q125 with
500 ng/mL leptin and 125 μM quercetin. Means without a common letter differ, at least p < 0.05.
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in leptin-induced HUVECs reduced the density of
NFκΒ. This phenomenon was confirmed by Western
blot analysis (Figure 4B). A further confirmation by
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Figure 3 Quercetin reduced leptin-induced ERK1/2 phosphorylation. (
that 500 ng/mL leptin exposure for 48 h increased ERK1/2 phosphorylation
did not show any effect (lane 2), nevertheless in leptin-induced HUVECs, ER
ERK1/2 level measured by ELISA was reduced after quercetin treatment on
quercetin; L0Q125 without leptin, but with 125 μM quercetin; L500Q0 with
leptin and 125 μM quercetin. Means without a common letter differ, at leaactivation in leptin-induced HUVECs when compared
to control (111.6 ± 24.35 vs. 692.4 ± 9.849 ng/mL, L0Q0
vs. L500Q0, p = 10-5). After quercetin addition, NFκB
activation was significantly reduced by 0.4x (304.4 ±
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Beta actin
A) Western blot analysis of phosphorylated ERK1/2 in HUVECs showed
(without (lane 1) and with (lane 3) leptin exposure). Quercetin alone
K1/2 phosphorylation was reduced (lane 4). (B) Total phosphorylated
leptin-induced HUVECs. L0Q0 control HUVECs without leptin and
500 ng/mL leptin, but without quercetin; L500Q125 with 500 ng/mL
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Figure 4 Quercetin inhibits leptin-induced NFκB activation. (A) FITC immunofluorescence labeling showed the signal density was increased
after 500 ng/mL leptin exposure as compared to control. Quercetin addition in leptin-induced HUVECs reduced the density of NFκΒ. Panel 1
control HUVECs without leptin and quercetin; panel 2 without leptin, but with 125 μM quercetin; panel 3 with 500 ng/mL leptin, but without
quercetin; panel 4 with 500 ng/mL leptin and 125 μM quercetin. (B) Western blot analysis of p65 NFκB in HUVECs confirmed the
immunofluorescence labeling. L0Q0 control HUVECs without leptin and quercetin; L0Q125 without leptin, with 125 μM quercetin; L500Q0 with
500 ng/mL leptin, without quercetin; L500Q125 with 500 ng/mL leptin and 125 μM quercetin. (C) ELISA measurement showed a significant
increased of NFκΒ activation in leptin-induced HUVECs when compared to control, and quercetin administration significantly reduced the
activated NFκB level. L0Q0 control HUVECs without leptin and quercetin; L0Q125 without leptin, but with 125 μM quercetin; L500Q0 with
500 ng/mL leptin, but without quercetin; L500Q125 with 500 ng/mL leptin and 125 μM quercetin. Means without a common letter differ,
p < 0.001.
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(Figure 4C).
Quercetin partially suppressed leptin-induced TNFα
secretion
Secreted TNFα level was markedly increased by 3.2x in
leptin-induced HUVECs as compared to control (22.39 ±
2.29 vs. 72.50 ± 7.33 ng/mL, L0Q0 vs. L500Q0, p = 10-4).
TNFα secretion was decreased, albeit partially (0.8x), after
quercetin addition in leptin-induced HUVECs (L500Q125)
when compared to leptin-induced HUVECs without quer-
cetin (L0Q125) (60.38 ± 1.04 vs. 72.50 ± 7.33 ng/mL,
L500Q125 vs. L500Q0, p = 0.022). TNFα secretation was
also increased when HUVECs were exposed to quercetin
alone (Figure 5).
Discussion
We have demonstrated the presence of the short chain
leptin receptor isoform Ob-Ra in HUVECs, confirming
previous studies [16,17]. We were able to show that
Ob-Ra expression was increased after leptin exposure.
Leptin has been reported to differentially modulate the
expression of its receptors in both dose- and tissue-
dependent manner [18]. When treated with high leptin
concentration, the level of leptin receptor was increased,
reported to be due to changes in receptor number that
occur prior to gene expression changes [19], which was
expected to happen post translationally [20].
We observed that up-regulated Ob-Ra expression was
followed by elevated ERK1/2 phosphorylation, in line
with previous reports that demonstrated ERK1 and
ERK2 activation by the short leptin receptor isoform
[21], and leptin-stimulated pro-inflammatory cytokine
release abrogation by ERK 1/2 MAPK inhibitor U0126a
b
Figure 5 Quercetin partially suppressed leptin-induced TNFα secretio
compared to control, and was partially decreased after quercetin addition.
leptin, but with 125 μM quercetin; L500Q0 with 500 ng/mL leptin, but with
quercetin. Means without a common letter differ, at least p < 0.05.[22]. As shown from our result, the elevated ERK1/2
phosphorylation was followed by increased NFκB acti-
vation and TNFα secretion, which was in agreement
with a previous report that indicated leptin has pro-
inflammatory action, involving pro-inflammatory cyto-
kines TNFα through NFκB regulation [22].
Quercetin is one of the most widely distributed flavo-
noids in fruits, vegetables, tea and wine [23], reported to
have anti-inflammatory properties, and might act as
health-promoting substances [24,25]. In this study, we
showed that 125 μM quercetin was able to down-
regulate Ob-Ra expression, reduce ERK1/2 phosphoryl-
ation, decrease NFκB activation, and partially suppress
TNFα secretion in leptin-induced HUVECs. The anti-
inflammatory effect of quercetin has been described in
various reports, among others were the ability to sup-
press ERK phosphorylation in 3 T3-L1 adipocytes [26]
and NCI-H292 cells [27], inhibit NFκB activation in
murine J774 macrophages [28] and bone marrow-
derived macrophages [29], VAT TNFα production in
obese Zucker rats [30], reduce the activation of phos-
phorylated ERK kinase strongly in LPS-induced RAW
264.7 cells and inhibit NFκB activation through both
stabilization of NFκB/IκB complex and suppression of
proinflammatory cytokines including TNFα [31]. In
PBMC, a 50% reduction of TNFα gene expression was
observed after 24 h exposure to 50 μM quercetin [14]. A
meta-analysis of long-term placebo-controlled human
intervention trials reported that TNFα levels were de-
creased after flavonoid consumption, but only in a fixed
model, and a higher dose or a longer duration interven-
tion were not associated with a greater effect size [32].
Although preliminary, our data suggested that suppres-
sion of TNFα secretion by quercetin was associated withd
c
n. TNFα secretion was markedly increased in leptin-induced HUVECs as
L0Q0 control HUVECs without leptin and quercetin; L0Q125 without
out quercetin; L500Q125 with 500 ng/mL leptin and 125 μM
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[28]. However, our result showed that quercetin suppres-
sion of TNFα secretion appeared to be partial, which we
believe might be due to the short duration of quercetin
exposure period. Although essential, unfortunately we
can not perform further confirmation of TNFα suppres-
sion by TNFα mRNA assessment, since our samples
were not prepared and stored for RNA analysis. This is
the limitation of our study, besides that we only apply
one quercetin concentration in our study, which might
not be the optimum concentration. Further studies, such
as measurements of TNFα mRNA and application of
NFkB activation inhibitor, are still needed to clarify this
discrepancy.
The suppression of inflammation by quercetin may have
clinical significance in preventing cardiovascular disease
induced by leptin-resistant in obesity. As reported previ-
ously, quercetin administration to obese Zucker rats im-
proved dyslipidemia, hypertension, and hyperinsulinemia,
all of which are cardiovascular risk factors [30]. A deeper
assessements on the molecular mechanisms of quercetin
action in suppressing leptin-induced inflammation are
needed as high intake of plant-derived food rich in quer-
cetin or the use of supplements of this flavonoid might be
protective and could reduce cardiovascular risks. It might
also be a promising area for the development of a
flavonoid-based neutrapharmaceutical agents for the treat-
ment of chronic inflammatory disease.
Conclusion
Leptin exposure of HUVECs resulted in up-regulated
Ob-Ra expression and elevated ERK1/2 phosphorylation
and NFkB activation, and increased TNF-alpha secre-
tion. Despite strong suppression effect of quercetin on
the increased Ob-Ra expression, ERK1/2 phosphoryl-
ation and NFkB activation, however, TNFα secretion was
only partially suppressed. Therefore, further studies are
still needed to elucidate the basis of this exception.
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